跳至主要内容
临床试验/NCT02925312
NCT02925312已完成不适用

MedStar Pathway to Diabetes Control Demonstration Project: Type 2 Diabetes Boot Camp

Medstar Health Research Institute2 个研究点 分布在 1 个国家目标入组 419 人开始时间: 2014年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
419
试验地点
2
主要终点
Percentage Change in Hemoglobin A1C From Baseline to 3 Months

研究概览

简要总结

A Diabetes Institute (MDI), in partnership with key stakeholders-including Primary Care Providers- in a northeastern US regional, mixed-payer healthcare system), seeks to implement an evidence-based, technology-enabled, innovative, and integrated diabetes care management pathway (Boot Camp) for adult patients with uncontrolled type 2 diabetes (A1C>/=9%) which will demonstrate improvement in diabetes clinical and health resources utilization outcomes.

详细描述

  • The program is designed to integrate type 2 diabetes specialty services into Primary Care practices to support PCPs and their patients in improving a spectrum of diabetes-related outcomes.
  • High-risk patients from Primary Care practices who have uncontrolled type 2 diabetes and meet the target population inclusion and exclusion criteria will be invited to participate in an intensive and concise "BOOT CAMP" medication management and education intervention of ~4-8 weeks duration.
  • The intervention will consist of three key components: (1) intensive, algorithm-based medication management (Appendix A), based on continuous review and management of blood sugars; (2) survival skills diabetes self-management education based on knowledge deficits identified on the KNOW Diabetes knowledge survey; (3) enhanced patient-provider communication, all provided by Endocrinologist supervised allied health professionals (in this instance CDEs).
  • Survival skills DSME will focus on nutrition and meal plan basics, blood glucose targets, taking medications as prescribed, hyper- and hypoglycemia recognition and treatment, and when to seek medical help.
  • The intervention is initiated with one to two face-to-face meetings with the CDE, at which the patient's readiness to change is assessed.
  • These are followed by virtual meetings though a variety of media based on patient preference and health literacy (largely telephone and text messaging).
  • Various technology tools are used to facilitate patient engagement, access and attainment of glycemic targets, including smart meters, virtual meeting platforms, web-based education content and surveys administration via tablets, etc.
  • Near real-time transmission of blood glucose data using a cellular-enabled blood glucose monitoring system sends all glucose results to a web-based dashboard accessed daily by the Boot Camp educators.
  • Concurrent matched charts of patients receiving standard care at the three MedStar locations will serve as a basis of comparison in assessing the impact of MDI on clinical and education outcomes and process of care.
  • Based on patient progress towards improved glycemic control, the patient will 'graduate' from the program and the CDE will refer the patient back to their PCP in 8-12 weeks with a full report of medication changes, blood glucose readings and further diabetes management recommendations eg referrals; further DSME, etc.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of type 2 diabetes for >=1 year
  • Active practice patient
  • A1C > 9.0% at their last visit to Medical Home, ED or hospital admission plus one more high risk factor (ED visit or hospitalization in past 12 mos)
  • Primary Care Provider willing to have patient enter the program
  • Patient is able and willing to participate in the program and exhibits readiness to change DM self-management
  • Proficient in English

排除标准

  • Known history of DKA
  • No MedStar PCP visit within past 12 months
  • Endocrine or Diabetes Education consult referral order in the past 6 months which resulted in Endo visit(s) or DSME visit(s) documented in chart or self-reported by patient during initial screen
  • Active additional medical issues which in the opinion of the care team would preclude concentrating on BG control and/or would predispose to ED visits and/or hospital admits independent of glycemic control, e.g.: severe CHF, severe COPD; severe mental illness.
  • Resident of skilled nursing facility, nursing home or receiving home health care services.
  • Active cancer in the preceding 3 years excluding nonmalignant basal cell cancer
  • Supraphysiologic doses of glucocorticoids (hydrocortisone > 30mg/day; prednisone > 5-6mg daily; dexamethasone > 2mg daily).
  • Pregnant or anticipates attempting conception in the following year
  • Patient and/or custodial caregiver unwilling and/or unable to participate in program-related activities

结局指标

主要结局

Percentage Change in Hemoglobin A1C From Baseline to 3 Months

时间窗: 3 months

Comparison of the percentage change in A1C from baseline to 3 months between the intervention and the control group

次要结局

  • Risk of Experiencing a Composite Endpoint of All Cause ED Visits and Hospitalizations at 6 Months Post Intervention vs 6 Months Pre-intervention for Cases and Controls.(6 months)
  • Adherence to Prescribed Diabetes Medications(90 days)
  • Frequency of Eye Exams(90 days)

研究者

发起方
Medstar Health Research Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Michelle Magee

Director, MedStar Diabetes Institute

Medstar Health Research Institute

研究点 (2)

Loading locations...

相似试验